©iStockphoto.com/naumoid
by Mary Jessica Hammes
April 07, 2008
My friend Allison had a rough week not long ago, to put it mildly.
First, she and her 19-month old son, Asher, flew across country (to attend a funeral, no less). Traveling alone with a toddler would be trying enough, but then, the morning of their return home, Asher started vomiting.
A lot.
He vomited in the hotel. He vomited on the airplane. He vomited during the hour-plus drive from the airport back home.
And then the real fun started—diarrhea, skyrocketing temperature, dehydration, and two days in the hospital.
Poor Asher (and poor Asher’s parents). He had rotavirus, a disease that causes 2.7 million cases of gastroenteritis in the U.S. each year.
Perhaps other children can now escape a similar hospital stay. On April 3, the U.S. Food and Drug Administration approved a second oral vaccine—Rotarix, made by GlaxoSmithKline—that prevents rotavirus.
“I think that knowing what I know, and having been through it, I probably would not do the vaccine,” says Allison. “I mean, it was an intense experience, and I hated seeing Asher feel so badly, but not all kids who get it [rotavirus] get so sick that they have to go the hospital. And even though we did, the hospital was just exactly what he needed and got him through it just fine. I guess it’s the devil you know versus the devil you don’t know.”
What the devil is she talking about? It turns out that this new vaccine might give some parents pause.
What’s the fuss?
In electron micrographs, rotaviruses look innocuous—more like a handful of just-picked, fuzzy dandelion clocks than a nasty virus that lands about 55,000–70,000 U.S. children in the hospital each year. And it’s life-threatening, causing 20-60 deaths a year. The FDA says that without the vaccination, nearly every child in the U.S. will be infected at least once by the age of 5.
Cheery thought. Well, let’s all get vaccinated, right?
Hold on. Did you notice that this is the second oral vaccine to be approved?
Wait, there was a first vaccine?
Yes, indeed. There’s even a rival vaccine (Merck & Co Inc’s Rotateq, which was approved two years ago), which, truthfully, I have never even heard of over the course of our son’s somewhat delayed vaccination schedule. The discernible difference to parents is that Rotateq is given in three doses, while Rotarix is given in two.
The big stink about any rotavirus vaccine stems from one called RotaShield (made by Wyeth) that was removed from the U.S. market in 1999 (less than a year after it went on the market), because it was linked to increased risk of intussusception, which is intestinal folding. That can be life-threatening, and sometimes requires surgery to unfold the intestine.
The thing is, there were warning signs all along. During clinical trials, there were reports of intussusception 30 times the normal rate. The FDA approved it anyway in August 1998, and in early 1999, the Centers for Disease Control and Prevention (CDC) added it to its list of recommended vaccines. Yet, by June 1999, epidemiologists began reporting unusual numbers of intussusception cases. In July, both the CDC and the American Academy of Pediatrics recommended that the vaccine be suspended. The Association of American Physicians and Surgeons wrote several statements critical of the vaccine, and in a letter to Congress asked why the vaccine had been approved at all.
And now, there have been similar concerns about Rotarix before it was approved, too. To the casual observer, it might seem worrying—that history is repeating itself.
According to a Reuters report published February 15 (just months before Rotarix was approved), the FDA then reported links between this vaccine and increased pneumonia-related deaths, convulsions, and rates of bronchitis.
On the FDA website, you can download the product approval information for the vaccine, and it’s decidedly more reassuring.
“The risk of intussusception with Rotarix was evaluated in a safety study (including 63,225 infants) conducted in Latin America and Finland,” reads the document. “No increased risk of intussusception was observed in this clinical trial following administration of Rotarix when compared with placebo.”
However, intussusception (along with blood and lymphatic system disorders) is listed as one of the side effects in post-marketing experience, reported outside the U.S. But, reads the product approval information, “because these events are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a casual relationship to vaccination with Rotarix.”
In an official statement, the FDA says studies showed no increased risk of intussusception (though common side effects reported during trials included fussiness, irritability, cough, runny nose, fever, loss of appetite, and vomiting).
Says the statement: “Although the FDA has concluded that the available data do not establish that these events are related to the vaccine, the agency has requested the manufacturer to conduct post-marketing safety studies involving more than 40,000 infants to provide additional safety information.”
What should parents do?
If you have concerns, and are not opposed to the possibility of your child getting rotavirus in the meantime, you can always take the “wait and see” approach.
“As much as I would hate to end up in the hospital, I think I would hate intestinal blockages caused by a vaccine even more,” says Christmas, mom to Rinney, 4, and Neil, 2. “I know this was reported with the previous rotavirus vaccine they developed, not the new one, but that’s enough to scare me into waiting at least five years or so to see what the potential kinks might be with the new one… and by that time, my kids would have already been exposed to this virus several times, anyway.”
Jenny, an emergency physician, holds a similar view, and chose to pass on the rotavirus vaccine for her 1-year-old son.
“Medically, I tend to hold off prescribing new medications, because I feel more comfortable waiting to see if new side effects arise,” she says. “I felt that as rotavirus is rarely fatal, and I know how to recognize and treat it, that it wasn’t worth the risk of intussusception or other side effects for my son Riley.”
Angie was one mom who did have concerns, but after researching the issue and asking a lot of questions at her pediatrician’s office, she opted for the vaccine for her 1-year-old daughter—and, she says, she couldn’t be happier.
“Ella has not had any reactions to any of the vaccines she has gotten, including Rotavirus,” she says. “I haven’t even noticed a low grade fever, so I have been very happy with the vaccines, the schedule and so far the outcome. I am particularly happy with the Rotavirus vaccine because after she had the 24 hour stomach bug, I absolutely do not want her to get Rotavirus!”
Vaccines are a hotly debated issue; as previously reported by baby gooroo. Some parents are choosing to delay or outright reject routine vaccinations. When it comes to a new one, weigh your options—Can you afford a hospital stay if it comes to that? Are you willing to deal with severe side effects?—and trust your instincts.